Revelation Biosciences, Inc.
REVBNasdaqCIK 1810560HealthcareFiscal year ends Dec 31
Reports and events: 160 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1917:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-357120 |
| 2026-08-0616:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338097 |
| 2026-08-0616:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-337967 |
| 2026-07-1316:05 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-302008 |
| 2026-06-2416:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-281200 |
| 2026-06-0117:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-251784 |
| 2026-05-1109:56 ET | DEF 14A | Proxy statementPeriod 2026-06-24 | 0001193125-26-215804 |
| 2026-05-0716:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-212064 |
| 2026-05-0716:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211871 |
| 2026-03-1916:18 ET | 8-K | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-116012 |
| 2026-02-2616:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076833 |
| 2026-02-2616:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076552 |
| 2026-02-1712:35 ET | DEF 14A | Proxy statementPeriod 2026-02-14 | 0001193125-26-053984 |
| 2026-01-2918:46 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-26-027742 |
| 2026-01-2219:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-018332 |
| 2025-12-0317:01 ET | 8-K | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-306915 |
| 2025-11-1014:57 ET | DEF 14A | Proxy statementPeriod 2025-12-03 | 0001193125-25-273712 |
| 2025-11-0616:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269696 |
| 2025-11-0616:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269450 |
| 2025-10-2916:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-256367 |
| 2025-10-1517:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-240400 |
| 2025-09-2216:15 ET | DEF 14A | Proxy statementPeriod 2025-09-22 | 0001193125-25-211333 |
| 2025-09-1517:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-203750 |
| 2025-09-0908:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001810560-25-000006 |
| 2025-08-0808:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105485 |
| 2025-08-0818:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105284 |
| 2025-07-0916:17 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-094789 |
| 2025-06-2516:26 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-25-089972 |
| 2025-06-0916:51 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0000950170-25-083815 |
| 2025-06-0416:05 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-081604 |
| 2025-05-2816:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0000950170-25-078340 |
| 2025-05-2309:56 ET | S-1/A | Registration statement, amended | 0001213900-25-047104 |
| 2025-05-2014:20 ET | S-1 | Registration statement | 0001213900-25-045828 |
| 2025-05-0816:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-067043 |
| 2025-05-0816:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066897 |
| 2025-03-1716:17 ET | 8-K | 8.01 Other events | 0000950170-25-040294 |
| 2025-03-0616:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034689 |
| 2025-03-0616:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034584 |
| 2025-02-2416:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-025626 |
| 2025-02-1116:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-017882 |
| 2025-01-3017:19 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-011197 |
| 2025-01-2116:31 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-007303 |
| 2025-01-0716:05 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-002828 |
| 2024-12-1608:54 ET | DEF 14A | Proxy statementPeriod 2024-12-13 | 0000950170-24-136402 |
| 2024-12-1217:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135895 |
| 2024-12-0616:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134064 |
| 2024-11-0816:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124141 |
| 2024-11-0816:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124036 |
| 2024-10-2116:19 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-24-115955 |
| 2024-09-2716:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-109998 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.